c ebpβ-lip drug The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse C/EBPβ sustains the oncogenic program
C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology C EBP beta Antibody Cell Signaling Technology Frontiers Emerging functions of C EBP in breast cancer A review of C EBP : a potential novel target for solid tumor intervention Journal of Translational Medicine Springer Nature Link Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link CCAAT Enhancer Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding Research
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




